Dr. Jay Walls, MD

NPI: 1821093956
Total Payments
$13,590
2024 Payments
$754.89
Companies
29
Transactions
86
Medicare Patients
2,026
Medicare Billing
$262,869

Payment Breakdown by Category

Other$10,200 (75.1%)
Food & Beverage$3,201 (23.6%)
Education$188.99 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,200 4 75.1%
Food and Beverage $3,201 80 23.6%
Education $188.99 2 1.4%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $10,728 14 $0 (2024)
Janssen Scientific Affairs, LLC $356.67 4 $0 (2023)
Incyte Corporation $353.71 7 $0 (2023)
Novartis Pharmaceuticals Corporation $201.68 8 $0 (2024)
Seagen Inc. $196.49 3 $0 (2023)
Gilead Sciences, Inc. $185.96 6 $0 (2024)
AstraZeneca Pharmaceuticals LP $184.12 5 $0 (2024)
Merck Sharp & Dohme LLC $160.13 3 $0 (2024)
PFIZER INC. $145.61 4 $0 (2024)
Epizyme, Inc., $121.42 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $754.89 24 AstraZeneca Pharmaceuticals LP ($164.91)
2023 $1,412 38 Incyte Corporation ($244.10)
2022 $375.61 6 Incyte Corporation ($109.61)
2021 $354.71 4 Epizyme, Inc., ($121.42)
2019 $61.72 1 Janssen Pharmaceuticals, Inc ($61.72)
2018 $148.56 3 Seattle Genetics, Inc. ($99.00)
2017 $10,483 10 Janssen Pharmaceuticals, Inc ($10,268)

All Payment Transactions

86 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/18/2024 PFIZER INC. INLYTA (Drug), PADCEV Food and Beverage In-kind items and services $24.06 General
Category: ONCOLOGY
12/09/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $23.70 General
Category: ONCOLOGY
11/20/2024 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Food and Beverage In-kind items and services $18.44 General
Category: Oncology
11/16/2024 ARRAY BIOPHARMA INC LORBRENA (Drug), BRAFTOVI, MEKTOVI Food and Beverage In-kind items and services $18.52 General
Category: ONCOLOGY
11/11/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $31.23 General
10/23/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $26.04 General
Category: Oncology
10/18/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $31.40 General
10/09/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $21.29 General
Category: Rare Disease
09/18/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $34.99 General
Category: ONCOLOGY
09/16/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $28.88 General
09/11/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $16.53 General
Category: Oncology
09/04/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $34.98 General
Category: Hematology
08/28/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $14.48 General
Category: ONCOLOGY
08/15/2024 Lilly USA, LLC VERZENIO (Drug), RETEVMO, JAYPIRCA Food and Beverage In-kind items and services $20.07 General
Category: Oncology
07/31/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $23.44 General
Category: Oncology
07/24/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $23.93 General
Category: Oncology
06/27/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $29.98 General
Category: Oncology
06/25/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $106.50 General
Category: Rare Disease
06/05/2024 Bayer Healthcare Pharmaceuticals Inc. Stivarga (Drug) Food and Beverage In-kind items and services $27.65 General
Category: Oncology
06/05/2024 PFIZER INC. INLYTA (Drug), XTANDI, TALZENNA Food and Beverage In-kind items and services $22.26 General
Category: ONCOLOGY
05/09/2024 PFIZER INC. INLYTA (Drug), XTANDI, TALZENNA Food and Beverage In-kind items and services $22.50 General
Category: ONCOLOGY
04/25/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $97.99 General
Category: Cardiovascular & Metabolism
04/18/2024 CSL Behring HEMGENIX (Biological) Food and Beverage In-kind items and services $24.85 General
Category: Hematology
02/05/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $31.18 General
12/26/2023 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $28.01 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 389 816 $131,528 $55,676
2022 6 516 910 $154,996 $65,936
2021 7 555 1,103 $184,788 $82,082
2020 8 566 1,088 $165,681 $59,174
Total Patients
2,026
Total Services
3,917
Medicare Billing
$262,869
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 194 435 $69,438 $28,165 40.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 62 167 $37,200 $17,364 46.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 116 197 $20,504 $8,783 42.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 17 17 $4,386 $1,364 31.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 223 440 $69,806 $29,399 42.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 88 201 $44,196 $20,716 46.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 121 170 $17,176 $7,328 42.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 29 29 $9,826 $3,881 39.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 30 30 $8,032 $2,441 30.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 25 40 $5,960 $2,171 36.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 230 484 $75,981 $33,799 44.5%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 95 250 $54,626 $26,491 48.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 137 236 $23,908 $10,585 44.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 31 71 $10,579 $3,913 37.0%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 32 32 $8,402 $2,996 35.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 17 17 $6,963 $2,499 35.9%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 13 13 $4,329 $1,800 41.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 179 448 $69,888 $24,965 35.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 191 344 $34,400 $11,555 33.6%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 48 109 $23,704 $8,712 36.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 54 90 $13,410 $4,961 37.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 27 27 $10,989 $4,136 37.6%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 37 37 $9,546 $3,610 37.8%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 15 15 $2,250 $687.94 30.6%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 15 18 $1,494 $547.50 36.6%

About Dr. Jay Walls, MD

Dr. Jay Walls, MD is a Hematology & Oncology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821093956.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Walls, MD has received a total of $13,590 in payments from pharmaceutical and medical device companies, with $754.89 received in 2024. These payments were reported across 86 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,200).

As a Medicare-enrolled provider, Walls has provided services to 2,026 Medicare beneficiaries, totaling 3,917 services with total Medicare billing of $262,869. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Greenville, SC
  • Active Since 06/16/2005
  • Last Updated 06/15/2021
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1821093956

Products in Payments

  • XARELTO (Drug) $11,057
  • ADCETRIS (Biological) $174.53
  • KEYTRUDA (Biological) $160.13
  • JAKAFI (Drug) $135.36
  • TAZVERIK (Drug) $121.42
  • ELIQUIS (Drug) $117.51
  • MONJUVI (Drug) $109.61
  • ANDEXXA (Biological) $106.50
  • COSELA (Drug) $83.85
  • SCEMBLIX (Drug) $77.33
  • XPOVIO (Drug) $70.55
  • AYVAKIT (Drug) $69.75
  • INLYTA (Drug) $68.82
  • VERZENIO (Drug) $62.56
  • Enhertu (Drug) $51.71
  • Nubeqa (Drug) $48.71
  • CALQUENCE (Drug) $39.97
  • REBLOZYL (Biological) $34.98
  • MONOFERRIC (Drug) $30.93
  • Trodelvy (Drug) $30.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Greenville